Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Roxanna S. Dronca"'
Autor:
Reem M. Alhammad, MD, Roxanna S. Dronca, MD, Lisa A. Kottschade, CNP, Heidi J. Turner, BS, Nathan P. Staff, MD, PhD, Michelle L. Mauermann, MD, Jennifer A. Tracy, MD, Christopher J. Klein, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 1, Iss 2, Pp 192-197 (2017)
Recently, guidelines have been outlined for management of immune-related adverse events occurring with immune checkpoint inhibitors in cancer, irrespective of affected organ systems. Increasingly, these complications have been recognized as including
Externí odkaz:
https://doaj.org/article/b370f541321d41759893f9a0cc1536f9
Autor:
Heidi J. Turner, Roxanna S. Dronca, Michelle L. Mauermann, Jennifer A. Tracy, Christopher J. Klein, Nathan P. Staff, Lisa A. Kottschade, Reem Alhammad
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 1, Iss 2, Pp 192-197 (2017)
Recently, guidelines have been outlined for management of immune-related adverse events occurring with immune checkpoint inhibitors in cancer, irrespective of affected organ systems. Increasingly, these complications have been recognized as including
Autor:
Sean S. Park, Ryan S. Youland, Lisa A. Kottschade, Roxanna S. Dronca, Kenneth R. Olivier, Svetomir N. Markovic, Miran Blanchard
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 6, Iss C, Pp 25-30 (2017)
Clinical and Translational Radiation Oncology, Vol 6, Iss C, Pp 25-30 (2017)
Background: To assess the role of radiotherapy in metastatic malignant melanoma (MM) patients in modern era. Materials and methods: This is a retrospective study of MM patients treated with radiotherapy at Mayo Clinic from 1999 to 2014. Patients with